Skip to content

Newsroom

Light through the canopy.

Company announcements, financial results, brand launches and milestones from across Canopy Growth's global business — traced along a single line of light.

Latest release

Financial Results

Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Q4 net revenue grew 27% in Canada Medical and 68% in International Markets Cannabis. The Company closed fiscal 2026 with $131.3M of net cash and reiterated its path to positive Adjusted EBITDA in fiscal 2027.

Read the full release
+68% International Markets Cannabis, Q4 Closed FY2026 with $131.3M net cash and a reiterated path to positive Adjusted EBITDA in fiscal 2027.

The archive

Every release, on the line.

JUNE 2026

Claybourne's Frosted Flyers Wins 'Best Infused Pre-Roll' at 2026 Grow Up Awards

Claybourne extends its market-share momentum with an expanded Frosted Flyers lineup — new variety formats built for flavour, discovery and summer pre-roll season.

Awards

MAY 2026

Canopy Growth Relaunches Tweed Brand in Germany with New MTL Cannabis Strain Lineup

First international release following the MTL acquisition. Pablo's Revenge, Dante'z Inferno and Frost'd Flakes launch under Tweed, targeting rapid growth in Germany's medical cannabis market.

Brand

Canopy Growth Provides Update on Financial Reporting; FY2026 Results to be Presented June 15, 2026

Canopy Growth (TSX: WEED) (Nasdaq: CGC) will release results for the fiscal year ended March 31, 2026 on June 15, 2026, and disclosed a technical, non-cash reclassification of certain warrants.

Financial Results

Spectrum Therapeutics Expands Medical Portfolio with New 30 and 90-Pack Softgels

Informed innovation delivers the same trusted quality with improved value, flexible dosing, and better alignment with patient needs across the Optimized Spectrum portfolio.

Medical

APRIL 2026

'There's a Tweed for That': Canopy Growth Announces Tweed Summer Campaign

New window bags, improved potency, and sharper pricing arrive at retail for the Victoria Day long weekend, alongside a national summer campaign.

Brand

MARCH 2026

Canopy Growth Unveils New Brand 'Deelish': High THC, Everyday Price

27%–33% THC flower and 26%–32% THC pre-rolls across rotating genetics — a new brand built for the everyday consumer, now in Ontario and Alberta.

Brand

Apollo Cannabis Clinics Named Best Medical Cannabis Clinic

Voted best by Toronto Star Readers' Choice Awards — a public vote reflecting the trust patients place in Apollo's care.

Awards

Canopy Growth Announces Storz & Bickel Executive Transition

David Männer appointed Managing Director as Jürgen Bickel passes the torch following 25 years building Storz & Bickel into a global premium vaporization leader.

Corporate

Canopy Growth Completes Acquisition of MTL Cannabis, Creating Canada's Leading Medical Cannabis Business by Revenue

Strengthens Canopy Growth's core Canadian platform, providing additional high-quality flower to support continued growth.

Corporate

Looking for older releases? View the full archive on canopygrowth.com.